Development and validation of DNA sequence-based methods of medicinal herb specie
Development and validation of DNA sequence-based methods of medicinal herb specie
批准号:
8303829
负责人:
Danica Taylor Harbaugh Reynaud
金额:
$20.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2013-07-31
关键词:
BotanicalsComplexConsumptionDNADNA SequenceDataDetectionDevelopmentEnsureGenesGinseng PreparationGlycyrrhiza uralensisGoldensealGuidelinesHerbal MedicineHousingHumanHybridsIndustryInternationalLaboratoriesLicoriceMedicinal HerbsMedicineMethodologyMethodsOrganismPanax ginsengPerformancePhasePowder dose formProbabilityProcessQualitative MethodsReference StandardsRegulationResearchRheumRhubarb foodSafetySamplingScientistScutellariaServicesSpecificitySpecimenTestingValidationbaseinnovationvalidation studies
中文摘要
在本提案中,我们概述了一种创新的方法来完成NCCAMs的至少两个优先事项:验证植物鉴定的DNA方法和开发复杂的DNA认证植物鉴定标准参考材料(BI-SRMs);这将对草药行业产生重大影响,有助于确保植物性药物的质量、安全性和有效性。使用DNA进行植物鉴定有许多优点:它可以用于鉴定来自各种材料类型的任何生物体,包括原料,粉末和精选加工产品;它非常敏感和强大,甚至可以从几个分子中识别物质;它有能力区分近亲物种、杂交物种,甚至物种内的谱系;并具有识别一种以上主要或污染物质混合物的能力,包括有毒或化学惰性掺假物或添加剂。在第一阶段,我们有两个具体的目标。在目标1中,我们将通过确定两个最佳候选DNA区域来进行预验证研究,以验证以下五个物种:甘草(glycyrhiza uralensis);
英文摘要
DESCRIPTION (provided by applicant): In this proposal, we outline an innovative approach to accomplish at least two of NCCAMs priorities: validating DNA methods for botanical identification and developing complex DNA-authenticated botanical identity standard reference materials (BI-SRMs); this will have significant impact on the medicinal herb industry by helping to ensure the quality, safety, and efficacy of botanical medicines. There are many advantages to using DNA for botanical authentication: it can be used to identify any organism from a variety of material types, including raw, powder, and select processed products; it is extremely sensitive and powerful and can identify material from even a few molecules; it has ability to discriminate between closely related species, hybrids, and even lineages within species; and has the ability to identify mixtures of more than one primary or contaminating species, including toxic or chemically inert adulterants or additives. In Phase 1 we have two specific aims, or objectives. In Objective 1, we will conduct a pre- validation study by identifying the two best candidate DNA regions for authentication of each of the following five species: licorice (Glycyrrhiza uralensis),
goldenseal (Hydrastis canadensis), ginseng (Panax quinquefolius), rhubarb (Rheum palmatum), and skullcap (Scutellaria lateriflora); these five species were chosen because are widely used in herbal medicine, have known issues of adulteration, and taxonomically confusing, and could benefit from having an alternative form of botanical identification. In Objective 2, we will conduc full single laboratory validation studies testing the specificity and performance for two gene regions for each of the five species on pure and impure samples following AOAC Internationals guidelines for qualitative method validation. This involves testing a total of 200 specimens representing the five species and their closely related adulterants, as well as 250 mixed samples, and calculating the Probability of Identification (POI). Through the products and services resulting from the research outlined in this proposal, we aim to bring DNA-authentication to the forefront of the medicinal herb industry.
PUBLIC HEALTH RELEVANCE: In this proposal we will complete the first full-validation studies on DNA methods of identification for five commonly used medicinal herbs: ginseng, goldenseal, licorice, rhubarb, and skullcap. Through the data generated here, we aim to bring DNA methods to the forefront of medicinal herb authentication, by allowing us to offer not only the first validated DNA testing services to the public, but also develop the first DNA- authenticated complex botanical identity standard reference materials to use for in-house testing and validation studies of alternative methods. These products and services will undoubtedly help in ensuring the safety, quality, and efficacy of medicinal herb products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Detection of Botanicals and Adulterants Using the Novel DNA-Based Technology "Seq
-
批准号:8708332
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Danica Taylor Harbaugh Reynaud
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TPLATE Complex通过胞吞调控CLV3-CLAVATA多肽信号模块维持干细胞稳态的分子机制研究
-
批准号:32370337
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:王杰
-
依托单位:
二甲双胍对于模型蛋白、γ-secretase、Complex I自由能曲面的影响
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郭子龙
-
依托单位:
高脂饮食损伤巨噬细胞ndufs4表达激活Complex I/mROS/HIF-1通路参与溃疡性结肠炎研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:赵锐
-
依托单位:
线粒体参与呼吸中枢pre-Bötzinger complex呼吸可塑性调控的机制研究
-
批准号:31971055
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:刘莹莹
-
依托单位:
北温带中华蹄盖蕨复合体Athyrium sinense complex的物种分化
-
批准号:31872651
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:张宪春
-
依托单位:
边缘鳞盖蕨复合体种 (Microlepia marginata complex) 的网状进化及物种形成研究
-
批准号:31860044
-
项目类别:地区科学基金项目
-
资助金额:37.0万元
-
批准年份:2018
-
负责人:王任翔
-
依托单位:
益气通络颗粒及主要单体通过调节cAMP/PKA/Complex I通路治疗气虚血瘀证脑梗死的机制研究
-
批准号:81703747
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:薛冰洁
-
依托单位:
生物钟转录抑制复合体 Evening Complex 调控茉莉酸诱导叶片衰老的分子机制研究
-
批准号:31670290
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:张媛媛
-
依托单位:
延伸子复合物(Elongator complex)的翻译调控作用
-
批准号:31360023
-
项目类别:地区科学基金项目
-
资助金额:51.0万元
-
批准年份:2013
-
负责人:黄波
-
依托单位:
Complex I 基因变异与寿命的关联及其作用机制的研究
-
批准号:81370445
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:杨泽
-
依托单位: